The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Targeting cancer cells with biotin–dendrimer conjugates
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175
Encapsulation of Guest Molecules into a Dendritic Box
Jansen, J. F. G. A., de Brabander-van den Berg, E. M. M., & Meijer, E. W. (1994) · Science · doi:10.1126/science.266.5188.1226 · Cited by 1,167
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
PATRI, A., KUKOWSKALATALLO, J., & BAKERJR, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.014 · Cited by 597
Majoros, I. J., Myc, A., Thomas, T., Mehta, C. B., & Baker, J. R. (2006) · Biomacromolecules · doi:10.1021/bm0506142 · Cited by 596
DEMANUELE, A., & ATTWOOD, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.012 · Cited by 571
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Bastida, Á., Sabuquillo, P., Armisén, P., Fernández‐Lafuente, R., Huguet, J., & Guisan, J. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980605)58:5<529::aid-bit9>3.0.co;2-f · Cited by 528
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Self-citationPoly(amidoamine) Dendrimer-Based Multifunctional Engineered Nanodevice for Cancer Therapy
Majoros, I. J., Thomas, T. P., Mehta, C. B., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0401863 · Cited by 395
Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours
Russell-Jones, G., McTavish, K., McEwan, J., Rice, J., & Nowotnik, D. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.07.009 · Cited by 392
Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
Gupta, U., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Biomacromolecules · doi:10.1021/bm050802s · Cited by 375
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269
Targeting and Inhibition of Cell Growth by an Engineered Dendritic Nanodevice
Thomas, T. P., Majoros, I. J., Kotlyar, A., Kukowska-Latallo, J. F., Bielinska, A., Myc, A., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040187v · Cited by 269
Patri, A. K., Myc, A., Beals, J., Thomas, T. P., Bander, N. H., & Baker, J. R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499127 · Cited by 249
Choi, Y., Thomas, T., Kotlyar, A., Islam, M. T., & Baker, J. R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.10.016 · Cited by 245
Polyamidoamine Starburst® dendrimers as solubility enhancers
Milhem, O. M., Myles, C., McKeown, N. B., Attwood, D., & D’Emanuele, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00463-9 · Cited by 227
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb
Shukla, R., Thomas, T. P., Peters, J. L., Desai, A. M., Kukowska-Latallo, J., Patri, A. K., Kotlyar, A., & Baker, J. R. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050348p · Cited by 213
Tumor angiogenic vasculature targeting with PAMAM dendrimer–RGD conjugates
Shukla, R., Thomas, T. P., Peters, J., Kotlyar, A., Myc, A., & Baker, Jr. (2005) · Chemical Communications · doi:10.1039/b507350b · Cited by 205
In vitro evaluation of dendrimer prodrugs for oral drug delivery
Najlah, M., Freeman, S., Attwood, D., & D’Emanuele, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.047 · Cited by 195
Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060367 · Cited by 190
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Cheng, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2774 · Cited by 184
Self-citationTargeting Cancer Cells with Dendrimers
Sampathkumar, S., & Yarema, K. J. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.12.007 · Cited by 70
Luo, S., Kansara, V. S., Zhu, X., Mandava, N. K., Pal, D., & Mitra, A. K. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500768 · Cited by 60
Kansara, V. S., Luo, S., Budda, B., Pal, D., & Mitra, A. K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.045 · Cited by 32
Cited by
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Mishra, B., Patel, B. B., & Tiwari, S. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.008 · Cited by 771
Metadata
- Authors
- Yang, W., Cheng, Y., Xu, T., Wang, X., & Wen, L.-P.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 44
- Issue
- 2
- Pages
- 862-868
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1964547598
- Cited by
- 290
- References
- 34
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.